RIGENERA 2.0 Trial

NCT02502747 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped slow enrolment

Conditions

Anterior Myocardial Infarction
Heart Failure

Interventions

DRUG: rhu G-CSF
DRUG: optimal standard of care
PROCEDURE: Myocardial Contrast Echocardiography

Sponsor

Catholic University of the Sacred Heart